Follow-Up Dermatological Exams Every 3-6 months during MT-2 use, and at least once 3 months after stopping
This threshold was established based on the EUROLIVE clinical trial data and represents a meaningful minimum for biological activity
For immediate-release tablets, the maximum dose is 850-1000 mg once or twice daily
Whether this stems from the medication itself, the rapid physical changes, or pre-existing conditions remains unclear
Kanoski SE, Rupprecht LE, Fortin SM, et al
Before starting Establish baseline ALT, AST, and GGT levels 4-8 weeks Check for early changes Every 3 months Monitor ongoing response during weight loss Maintenance Test every 6 months If you have pre-existing fatty liver or insulin resistance, more frequent testing helps track improvement